I

INZY

Inozyme Pharma, Inc.

0.98

0.02+2.52%
After Hours: 1.030  +0.046  +4.64%19:17 04/25 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

123.18M

200.85M

139.19M

123.54M

169.36M

Total Current Assets

120.68M

196.25M

131.39M

115.34M

150.98M

Total Non Current Assets

2.51M

4.60M

7.80M

8.20M

18.38M

Total Liabilities

65.36M

60.37M

20.80M

14.27M

11.26M

Total Current Liabilities

33.90M

14.69M

14.71M

11.63M

9.97M

Total Non Current Liabilities

31.46M

45.68M

6.09M

2.64M

1.29M

Total Equity

57.83M

140.48M

118.39M

109.27M

158.10M

Total Stockholders Equity

57.83M

140.48M

118.39M

109.27M

158.10M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

123.18M

200.85M

139.19M

123.54M

169.36M

Total Common Shares Outstanding

64.24M

61.77M

40.39M

23.67M

23.38M

Total Preferred Shares Outstanding

--

--

--

--

--